Musculoskeletal effects of peroxisome proliferator activated receptor (PPAR) alpha and AMP-activated protein kinase (AMPK) agonists: Studies in rats and humans
- Prosjektnummer
- 46056712
- Ansvarlig person
- Mats Peder Mosti
- Institusjon
- NTNU, IKM
- Prosjektkategori
- Postdoc-stipend 2013
- Helsekategori
- Metabolic and Endocrine, Musculoskeletal
- Forskningsaktivitet
- 5. Treatment Developement
The PPARa Agonist Fenofibrate Improves the Musculoskeletal Effects of Exercise in Ovariectomized Rats.
Endocrinology 2016 Oct;157(10):3924-3934. Epub 2016 aug 15
PMID: 27526032
Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice.
J Endocrinol 2016 Aug;230(2):251-62. Epub 2016 jun 20
PMID: 27325243
Effects of the Histamine 1 Receptor Antagonist Cetirizine on the Osteoporotic Phenotype in H(+) /K(+) ATPase Beta Subunit KO Mice.
J Cell Biochem 2016 Sep;117(9):2089-96. Epub 2016 mar 4
PMID: 26869358
Impaired skeletal health in patients with chronic atrophic gastritis.
Scand J Gastroenterol 2016 Jul;51(7):774-81. Epub 2016 feb 8
PMID: 26854332
Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
Osteoporos Int 2016 Mar;27(3):1003-10. Epub 2015 okt 26
PMID: 26501558
- Astrid Kamilla Stunes Forsker
- Unni Syversen Prosjektleder
- Mats Peder Mosti Postdoktorstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU